(Sharecast News) - Ixico reported higher interim revenue and a larger order book on Tuesday, as new contract wins, extensions and increased biomarker analysis activity supported growth in the first half.
The AIM-traded neuroscience imaging and biomarker analytics company said revenue rose 23% to £3.9m for the six months ended 31...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE